CPRX Brian Elsbernd buys $908K worth of shares
Nov 15, 2025, 11:35 AM
0.00%
What does CPRX do
Catalyst Pharmaceuticals, based in Coral Gables, Florida, develops and commercializes novel medicines for rare diseases, including FIRDAPSE for Lambert-Eaton Myasthenic Syndrome and AGAMREE for Duchenne Muscular Dystrophy. The company, which went public in 2006, employs 167 people.
Brian Elsbernd bought 40,000 shares of CPRX on 12 November at $22.70 per share, worth a total of $908K. They now own 231,039 CPRX shares, or a 21% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.